Sponsored Webcast: Minimizing Medication Errors: Designing Safe Container and Carton Labeling (On-Demand)

1.0 RAC Credits Price: $0 Member | $25 NonMember
Sponsored Webcast: Minimizing Medication Errors: Designing Safe Container and Carton Labeling (On-Demand)

This is an on-demand recording from March 2022

In this webcast, experts from Med Safety Board, a subsidiary of the Institute for Safe Medication Practices, will review the significant changes that were incorporated into the finalized FDA guidance: Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors.


Price: $0 Member | $25 NonMember

Learning Objectives

Understand and apply FDA guidance on safe medication container labeling to minimize product-use errors and risks.

Audience Learning Level:

Intermediate: Content is designed based upon the assumption that individuals have basic knowledge of the topic(s) and/or demonstrated competence related to the topic(s). Higher-level concepts are introduced during lectures; exercises requiring synthesis and/or application of concepts are incorporated into the activity.

Who Should Attend?

Regulatory, quality, operations, and product management professionals within life science organizations.


Rebecca Lamis

Rebecca Lamis

Rebecca (Becky) Lamis, PharmD, FISMP, is a Medication Safety Analyst at the Institute for Safe Medication Practices. She also manages the Med Safety Board. Lamis began as a safe medication management fellow. She then assisted in developing and reviewing numerous ISMP medication safety tools, resources, and publications; analyzing medication error reports and self-assessment data submitted by healthcare facilities; and participating in onsite risk assessments. In her current role, she has led various packaging and labeling projects. Lamis also has experience utilizing failure mode and effects analysis as a risk assessment method. During a residency at Wesley Medical Center in Wichita, she gained valuable clinical experience in optimizing medication therapy and providing care to both adult and pediatric patients. She also conducted research and received training in grantsmanship and medication safety.

Kristine Needleman

Kristine Needleman

Kristine Needleman has been a pharmacist since 1994 and has taken an active role in medication safety from the beginning of her career. Needleman’s clinical experience spans retail pharmacy, community clinic settings, inpatient pharmacies, and operating-room pharmacies. She owns K Needleman Consulting, where she assists pharmaceutical companies in developing safe product labels and trademarks. She is interested in creating product packaging and labels with an eye toward error mitigation. Prior to opening her own shop, Needleman spent 17 years with ISMP. She is knowledgeable in Failure Mode and Effects Analysis and has been a team leader on several human factors testing projects. She earned an undergraduate degree in chemistry from Albion College and a BS in pharmacy from Ferris State University.


RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation.

All cancellation requests must be submitted in writing to raps@raps.org.  RAPS is unable to accept cancellations by phone.

To transfer a registration, email raps@raps.org with the event title, name of the original registrant, and contact information for the new attendee.

Proof of Attendance

A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.



For additional hands-on support, you can also connect with RAPS support 30 min prior to the workshophttps://www.raps.org/website/virtual-event-help

For account support, contact the RAPS Support Center: at +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email support@raps.org.

Add to Cart

Discover more of what matters to you

Advertising, Promotion and Labeling Audit/FDA Inspection Biologics Biotechnology Chemistry, Manufacturing and Controls (CMC) Clinical Trials Combination Products Compliance Diagnostics FDA meeting and communication strategy Global Medical Devices North America OTC Pharmaceuticals Preclinical study Product Lifecycle Project management Quality Assurance and Control Regulatory Intelligence/Policy Research, Design and Development Supply Chain Management

News »